Tirosint FDA Approved Drugs
LEVO-T [Levothyroxine SodiumC15H10I4NO4Na5H2O]
RX
- 0.025mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.075mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.088mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.125mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.137mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.15mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.175mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.1mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.2mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.3mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
Alara PharmMar 1, 2002
LEVOTHYROXINE SODIUM [Levothyroxine SodiumC15H10I4NO4Na5H2O]
RX
- 0.025mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.075mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.088mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.125mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.137mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.15mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.175mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.1mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.2mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.3mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
100mcg/vial (intravenous powder)
200mcg/vial (intravenous powder)
500mcg/vial (intravenous powder)
MylanJun 5, 2002
Fera Pharms LlcJun 29, 2016
Fresenius Kabi UsaJun 24, 2011
Par Sterile ProductsDec 7, 2015
Fera Pharms LlcJun 29, 2016
Fresenius Kabi UsaJun 24, 2011
Par Sterile ProductsDec 7, 2015
LEVOXYL [Levothyroxine SodiumC15H10I4NO4Na5H2O]
RX
- 0.025mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.075mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.088mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.125mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.137mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.15mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.175mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.1mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.2mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
King PharmsMay 25, 2001
- Method of use of administering levothyroxine.
SYNTHROID [Levothyroxine SodiumC15H10I4NO4Na5H2O]
RX
- 0.025mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.075mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.088mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.125mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.137mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.15mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.175mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.1mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.2mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.3mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
AbbvieJul 24, 2002
TIROSINT [Levothyroxine SodiumC15H10I4NO4Na5H2O]
RX
- 0.013mg (oral capsule)
0.025mg (oral capsule)
0.05mg (oral capsule)
0.075mg (oral capsule)
0.088mg (oral capsule)
0.112mg (oral capsule)
0.125mg (oral capsule)
0.137mg (oral capsule)
0.15mg (oral capsule)
0.1mg (oral capsule)
Institut BiochimiqueAug 1, 2007
UNITHROID [Levothyroxine SodiumC15H10I4NO4Na5H2O]
RX
- 0.025mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.075mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.088mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.125mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.137mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.15mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.175mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.1mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.2mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.3mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
Stevens JAug 21, 2000
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.